BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 29332347)

  • 21. Notch1 downregulation combined with interleukin-24 inhibits invasion and migration of hepatocellular carcinoma cells.
    Han B; Liu SH; Guo WD; Zhang B; Wang JP; Cao YK; Liu J
    World J Gastroenterol; 2015 Sep; 21(33):9727-35. PubMed ID: 26361419
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bone marrow mesenchymal stem cells suppress ascitogenous hepatoma progression in BALB/c mouse through reducing myeloid-derived suppressor cells.
    Su X; Zhang L; Ye J; Yang L; Li Y; Wang Y
    Biomed Mater Eng; 2015; 25(1 Suppl):167-77. PubMed ID: 25538067
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transplantation of BMSCs expressing hPDGF-A/hBD2 promotes wound healing in rats with combined radiation-wound injury.
    Hao L; Wang J; Zou Z; Yan G; Dong S; Deng J; Ran X; Feng Y; Luo C; Wang Y; Cheng T
    Gene Ther; 2009 Jan; 16(1):34-42. PubMed ID: 18701914
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TGF-β1 is Involved in Vitamin D-Induced Chondrogenic Differentiation of Bone Marrow-Derived Mesenchymal Stem Cells by Regulating the ERK/JNK Pathway.
    Jiang X; Huang B; Yang H; Li G; Zhang C; Yang G; Lin F; Lin G
    Cell Physiol Biochem; 2017; 42(6):2230-2241. PubMed ID: 28817810
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A combination of ultrasound-targeted microbubble destruction with transplantation of bone marrow mesenchymal stem cells promotes recovery of acute liver injury.
    Sun T; Gao F; Li X; Cai Y; Bai M; Li F; Du L
    Stem Cell Res Ther; 2018 Dec; 9(1):356. PubMed ID: 30594241
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effect of human hepatocyte growth factor gene-modified bone marrow mesenchymal stem cells on immunological rejection after allograft liver transplantation in rats].
    Zhu J; Chen Y
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2011 Jul; 25(7):871-6. PubMed ID: 21818958
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human mesenchymal stem cells overexpressing pigment epithelium-derived factor inhibit hepatocellular carcinoma in nude mice.
    Gao Y; Yao A; Zhang W; Lu S; Yu Y; Deng L; Yin A; Xia Y; Sun B; Wang X
    Oncogene; 2010 May; 29(19):2784-94. PubMed ID: 20190814
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evodiamine Induces Apoptosis in SMMC-7721 and HepG2 Cells by Suppressing NOD1 Signal Pathway.
    Guo XX; Li XP; Zhou P; Li DY; Lyu XT; Chen Y; Lyu YW; Tian K; Yuan DZ; Ran JH; Chen DL; Jiang R; Li J
    Int J Mol Sci; 2018 Oct; 19(11):. PubMed ID: 30384473
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular targeting of VEGF/VEGFR signaling by the anti-VEGF monoclonal antibody BD0801 inhibits the growth and induces apoptosis of human hepatocellular carcinoma cells in vitro and in vivo.
    Liu L; Qin S; Zheng Y; Han L; Zhang M; Luo N; Liu Z; Gu N; Gu X; Yin X
    Cancer Biol Ther; 2017 Mar; 18(3):166-176. PubMed ID: 28368741
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of bone marrow mesenchymal stem cells on hepatocellular carcinoma in microcirculation.
    Gong P; Wang Y; Wang Y; Jin S; Luo H; Zhang J; Bao H; Wang Z
    Tumour Biol; 2013 Aug; 34(4):2161-8. PubMed ID: 23584896
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of bone-marrow-derived mesenchymal stem cells on high-potential hepatocellular carcinoma in mouse models: an intervention study.
    Li T; Song B; Du X; Wei Z; Huo T
    Eur J Med Res; 2013 Sep; 18(1):34. PubMed ID: 24079479
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recombinant Newcastle Disease Virus Encoding IL-12 and/or IL-2 as Potential Candidate for Hepatoma Carcinoma Therapy.
    Ren G; Tian G; Liu Y; He J; Gao X; Yu Y; Liu X; Zhang X; Sun T; Liu S; Yin J; Li D
    Technol Cancer Res Treat; 2016 Oct; 15(5):NP83-94. PubMed ID: 26303327
    [TBL] [Abstract][Full Text] [Related]  

  • 33. miR-145 Regulates Diabetes-Bone Marrow Stromal Cell-Induced Neurorestorative Effects in Diabetes Stroke Rats.
    Cui C; Ye X; Chopp M; Venkat P; Zacharek A; Yan T; Ning R; Yu P; Cui G; Chen J
    Stem Cells Transl Med; 2016 Dec; 5(12):1656-1667. PubMed ID: 27460851
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization and Validation of Hepatocellular Carcinoma (HCC) Xenograft tumor as a Suitable Liver Cancer Model for Preclinical Mesenchymal Stem Cell Studies.
    Hajighasemlou S; Pakzad S; Ai J; Muhammadnejad S; Mirmoghtadaei M; Hosseinzadeh F; Gharibzadeh S; Kamali A; Ahmadi A; Verdi J
    Asian Pac J Cancer Prev; 2018 Jun; 19(6):1627-1631. PubMed ID: 29936790
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Notch1 signaling inhibits growth of human hepatocellular carcinoma through induction of cell cycle arrest and apoptosis.
    Qi R; An H; Yu Y; Zhang M; Liu S; Xu H; Guo Z; Cheng T; Cao X
    Cancer Res; 2003 Dec; 63(23):8323-9. PubMed ID: 14678992
    [TBL] [Abstract][Full Text] [Related]  

  • 36. IL-17 promotes hepatocellular carcinoma through inhibiting apoptosis induced by IFN-γ.
    Li J; Zeng M; Yan K; Yang Y; Li H; Xu X
    Biochem Biophys Res Commun; 2020 Feb; 522(2):525-531. PubMed ID: 31784083
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The growth inhibitory effect of human gingiva-derived mesenchymal stromal cells expressing interferon-β on tongue squamous cell carcinoma cells and xenograft model.
    Du L; Liang Q; Ge S; Yang C; Yang P
    Stem Cell Res Ther; 2019 Jul; 10(1):224. PubMed ID: 31358054
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human Bone Marrow Mesenchymal Stem Cells Functionalized by Hybrid Baculovirus-Adeno-Associated Viral Vectors for Targeting Hypopharyngeal Carcinoma.
    Wang J; Zhu L; Chen X; Huang R; Wang S; Dong P
    Stem Cells Dev; 2019 Apr; 28(8):543-553. PubMed ID: 30747033
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Insulin-like growth factor binding protein 4 inhibits proliferation of bone marrow mesenchymal stem cells and enhances growth of neurospheres derived from the stem cells.
    Li H; Yu S; Hao F; Sun X; Zhao J; Xu Q; Duan D
    Cell Biochem Funct; 2018 Aug; 36(6):331-341. PubMed ID: 30028031
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HSCs-derived COMP drives hepatocellular carcinoma progression by activating MEK/ERK and PI3K/AKT signaling pathways.
    Li Q; Wang C; Wang Y; Sun L; Liu Z; Wang L; Song T; Yao Y; Liu Q; Tu K
    J Exp Clin Cancer Res; 2018 Sep; 37(1):231. PubMed ID: 30231922
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.